1. Analysis of the proximal promoter of the human colon-specific B4GALNT2 (Sda synthase) gene:B4GALNT2 is transcriptionally regulated by ETS1
- Author
-
Wavelet-Vermuse, C. (Cindy), Groux, S. (Sophie), Vicogne, D. (Dorothee), Cogez, V. (Virginie), Venturi, G. (Giulia), Trinchera, M. (Marco), Brysbaert, G. (Guillaume), Krzewinski, M-A. (Marie-Ange), Hadj Bachir, E. (Elsa), Schulz, C. (Celine), Vincent, A. (Audrey), Van Seuningen, I. (Isabelle), Harduin Lepers, A. (Anne), Université de Lille, CNRS, Unité de Glycobiologie Structurale et Fonctionnelle (UGSF) - UMR 8576, Miniaturisation pour la Synthèse, l'Analyse et la Protéomique (MSAP) - USR 3290, and Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
- Subjects
Transcriptional regulation ,Core promoter ,ETS1 ,Colon ,B4GALNT2 - Abstract
Background: The Sda antigen and corresponding biosynthetic enzyme B4GALNT2 are primarily expressed in normal colonic mucosa and are down-regulated to a variable degree in colon cancer tissues. Although their expression profile is well studied, little is known about the underlying regulatory mechanisms. Methods: To clarify the molecular basis of Sda expression in the human gastrointestinal tract, we investigated the transcriptional regulation of the human B4GALNT2 gene. The proximal promoter region was delineated using luciferase assays and essential trans-acting factors were identified through transient overexpression and silencing of several transcription factors. Results: A short cis-regulatory region restricted to the −72 to +12 area upstream of the B4GALNT2 short-type transcript variant contained the essential promoter activity that drives the expression of the human B4GALNT2 regardless of the cell type. We further showed that B4GALNT2 transcriptional activation mostly requires ETS1 and to a lesser extent SP1. Conclusions: Results presented herein are expected to provide clues to better understand B4GALNT2 regulatory mechanisms. 1864;11-12
- Published
- 2021